文献速递肝病

肝硬化门诊患者慢加急性肝衰竭的发病率、预测因素与结局

Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis.
PubMed 文献 · J Hepatol · 2017-07-19

该研究纳入466例连续就诊于三级医院门诊的肝硬化患者,平均随访45±44个月,25%发生慢加急性肝衰竭(ACLF),1年、5年、10年发生概率分别为14%、29%、41%,基线平均动脉压、腹水、MELD评分和血红蛋白是1年内发生ACLF的独立预测因素,ACLF患者3个月无移植生存概率为56%。

要点

  • 肝硬化门诊患者ACLF发生风险高,10年累计发生概率达41%。
  • 基线腹水(HR 2.53)、MELD评分(HR 1.26)与ACLF发生风险升高相关。
  • 基线平均动脉压(HR 0.96)和血红蛋白(HR 0.07)与ACLF发生风险降低相关。

核心结论

  • 肝硬化门诊患者发生ACLF的风险高。
  • 肝衰竭程度、循环功能障碍以及低血红蛋白水平与ACLF发生相关。
  • 这些简单变量可能有助于识别ACLF高危患者并规划密切监测和预防方案。
  • 贫血是治疗这些患者的潜在新靶点。

研究设计与样本

  • 研究纳入466例连续就诊于三级医院门诊的肝硬化患者,随访至死亡和/或肝移植,平均随访45±44个月。
  • ACLF依据EASL-CLIF联盟定义进行定义和分级。

主要发现

  • 随访期间118例(25%)发生ACLF:57例1级、33例2级、28例3级。
  • 发生ACLF的概率在1年、5年和10年分别为14%、29%和41%。
  • 多因素分析中,基线平均动脉压(HR 0.96;p=0.012)、腹水(HR 2.53;p=0.019)、终末期肝病模型评分(HR 1.26;p<0.001)和基线血红蛋白(HR 0.07;p=0.012)是1年内发生ACLF的独立预测因素。
  • ACLF与不良预后相关,3个月无移植生存概率为56%。

临床怎么用

  • 作者认为,这些简单变量可能有助于识别ACLF高危的肝硬化患者,这些患者是新的监测和预防策略的候选人群。
  • 作者认为,贫血是治疗这些患者的潜在新靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) is the most life-threatening complication of cirrhosis. Prevalence and outcomes of ACLF have recently been described in hospitalized patients with cirrhosis. However, no data is currently available on the prevalence and the risk factors of ACLF in outpatients with cirrhosis. The aim of this study was to evaluate incidence, predictors and outcomes of ACLF in a large cohort of outpatients with cirrhosis. METHODS: A total of 466 patients with cirrhosis consecutively evaluated in the outpatient clinic of a tertiary hospital were included and followed up until death and/or liver transplantation for a mean of 45±44months. Data on development of hepatic and extrahepatic organ failures were collected during this period. ACLF was defined and graded according to the EASL-CLIF Consortium definition. RESULTS: During the follow-up, 118 patients (25%) developed ACLF: 57 grade-1, 33 grade-2 and 28 grade-3. The probability of developing ACLF was 14%, 29%, and 41% at 1year, 5years, and 10years, respectively. In the multivariate analysis, baseline mean arterial pressure (hazard ratio [HR] 0.96; p=0.012), ascites (HR 2.53; p=0.019), model of end-stage liver disease score (HR 1.26; p<0.001) and baseline hemoglobin (HR 0.07; p=0.012) were found to be independent predictors of the development of ACLF at one year. As expected, ACLF was associated with a poor prognosis, with a 3-month probability of transplant-free survival of 56%. CONCLUSIONS: Outpatients with cirrhosis have a high risk of developing ACLF. The degree of liver failure and circulatory dysfunction are associated with the development of ACLF, as well as low values of hemoglobin. These simple variables may help to identify patients at a high risk of developing ACLF and to plan a program of close surveillance and prevention in these patients. LAY SUMMARY: There is a need to identify predictors of acute-on-chronic liver failure (ACLF) in patients with cirrhosis in order to identify patients at high risk of developing ACLF and to plan strategies of prevention. In this study, we identified four simple predictors of ACLF: model of end-stage liver disease (MELD) score, ascites, mean arterial pressure and hemoglobin. These variables may help to identify patients with cirrhosis, at a high risk of developing ACLF, that are candidates for new strategies of surveillance and prevention. Anemia is a potential new target for treating these patients.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Piano S, Tonon M, Vettore E, et al. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis. J Hepatol. 2017. PMID: 28733221. doi:10.1016/j.jhep.2017.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。